IN VIVO AND IN VITRO BIOTRANSFORMATION OF MOLNUPIRAVIR (MOV), AN ORAL PRODRUG OF THE ANTIVIRAL RIBONUCLEOSIDE ANALOG.-D-N4-HYDROXYCYTIDINE (NHC)

被引：0
|
作者：
Lu, Ping [1 ]
Miller, Randy [1 ]
Pang, Jianmei [1 ]
Smith, Sheri [1 ]
Hoar, Jason [1 ]
Concilla, Mark [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2024年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P122
引用
收藏
页数：2
相关论文
共 9 条
  • [1] β-D-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus
    Konishi, Kei
    Kusakabe, Shinji
    Kawaguchi, Nijiho
    Shishido, Takao
    Ito, Naoto
    Harada, Michiko
    Inoue, Satoshi
    Maeda, Ken
    Hall, William W.
    Orba, Yasuko
    Sawa, Hirofumi
    Sasaki, Michihito
    Sato, Akihiko
    ANTIVIRAL RESEARCH, 2024, 229
  • [2] Transfer and biotransformation of the COVID-19 prodrug molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-placenta barrier
    Chang, Chun-Hao
    Peng, Wen-Ya
    Lee, Wan-Hsin
    Lin, Tung-Yi
    Yang, Muh-Hwa
    Dalley, Jeffrey W.
    Tsai, Tung-Hu
    EBIOMEDICINE, 2023, 95
  • [3] Assessing the mitochondrial safety profile of the molnupiravir active metabolite, β-d-N4-hydroxycytidine (NHC), in the physiologically relevant HepaRG model
    Kiy, Robyn T.
    Khoo, Saye H.
    Chadwick, Amy E.
    TOXICOLOGY RESEARCH, 2024, 13 (01)
  • [4] Two short approaches to the COVID-19 drug β-<sc>d</sc>-N4-hydroxycytidine and its prodrug molnupiravir
    Persaud, Kevin E.
    Sahu, Rajesh R.
    Neary, Michelle C.
    Kapdi, Anant R.
    Lakshman, Mahesh K.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2024, 22 (04) : 735 - 740
  • [5] Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir?
    Clark, Nicole F.
    Taylor-Robinson, Andrew W.
    Heimann, Kirsten
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2022, 13
  • [6] Pharmacokinetics of ss-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    FitzGerald, Richard
    Dickinson, Laura
    Else, Laura
    Fletcher, Thomas
    Hale, Colin
    Amara, Alieu
    Walker, Lauren
    Penchala, Sujan Dilly
    Lyon, Rebecca
    Shaw, Victoria
    Greenhalf, William
    Bullock, Katie
    Lavelle-Langham, Lara
    Reynolds, Helen
    Painter, Wendy
    Holman, Wayne
    Ewings, Sean
    Griffiths, Gareth
    Khoo, Saye
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E525 - E528
  • [7] β-D-N 4-hydroxycytidine (NHC, EIDD-1931) inhibits chikungunya virus replication in mosquito cells and ex vivo Aedes aegypti guts, but not when ingested during blood-feeding
    Rosales-Rosas, Ana Lucia
    Soto, Alina
    Wang, Lanjiao
    Mols, Raf
    Fontaine, Albin
    Sanon, Aboubakar
    Augustijns, Patrick
    Delang, Leen
    ANTIVIRAL RESEARCH, 2024, 225
  • [8] Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects
    Liu, Jian
    Zhao, Qingwei
    Zhai, You
    Wu, Xia
    Kai, Jiejing
    Ruan, Jie
    Wu, Minglan
    Wu, Meijia
    Zhou, Zhuojun
    Yan, Yuemei
    Wu, Jinzi J.
    Qiu, Yunqing
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024,
  • [9] Prediction of differences in in vivo oral clearance of N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100) between extensive and poor metabolizers from in vitro metabolic data in human liver microsomes lacking CYP2D6 activity and recombinant CYPs
    Yamamoto, T
    Hagima, N
    Nakamura, M
    Kohno, Y
    Nagata, K
    Yamzoe, Y
    XENOBIOTICA, 2004, 34 (07) : 687 - 703
1